Meyka Pro banner
Supernus, Inc.

Supernus, Inc. (SUPN) Stock Overview

Explore Supernus, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SUPN●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$29.45
$0.70(2.43%)
U.S. Market opens in 1h 11m

Supernus, Inc. (SUPN)

Meyka AI Score

Z

Key Financials

Market Cap1.7B
P/E Ratio8.04
EPS (TTM)$-0.76
ROE-3.53%
Fundamental Analysis

AI Price Forecasts

1 Month$28.69
3 Months$35.15
1 Year Target$53.49

SUPN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Supernus, Inc. (NASDAQ: SUPN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Supernus, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SUPN on the NASDAQ shows an RSI of 30.86, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $53.49 for the NASDAQ listing.

Key metrics behind Supernus, Inc.'s NASDAQ-traded stock include a P/E ratio of 8.04 and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SUPN on the NASDAQ.

Price Performance (NASDAQ: SUPN)

1-Day Change
2.43%
5-Day Change
10.80%
1-Month Change
-17.81%
3-Month Change
-23.37%
6-Month Change
-24.18%
Year-to-Date (YTD) Change
-17.92%
1-Year Change
-5.21%
3-Year Change
87.22%
5-Year Change
84.06%
All-Time (Max) Change
448.42%

Contact Information

NaN
9715 Key West Avenue, Rockville, MD, 20850

Company Facts

8,270 Employees
IPO DateApr 30, 2012
CountryUS
Actively Trading

Frequently Asked Questions